Particle surface modification is becoming an important strategy in the pharmaceutical industry for “difficult to formulate” APIs. Most surface modification techniques, however, alter innate particle properties either chemically or physically. This technology is a one-step, ambient temperature process, with controlled processing parameters that can deliver repeatable product performance with commercially available excipients.
